Plasma is the yellow liquid component of blood in which the blood cells in whole blood are normally suspended.  Plasma is derived from whole blood collected from donor subjects or apheresis.  Important elements in plasma include albumin, coagulation factors, fibrinolytic proteins, immunoglobulin, and other proteins.

 

Plasma can be produced on demand and provided fresh or from a frozen inventory.

 

If possible, HemaCare will utilize any commercially available anticoagulant per your specifications:

 

ACD
ACDA
Citrate Phosphate Dextrose
CPD
CPDA-1
CTAD
EDTA (Potassium)
EDTA (Sodium Fluoride) EDTA (Sodium)
Heparin (Lithium)
Heparin (Sodium)
K2 EDTA
K3 EDTA
Lithium Heparin
Potassium Oxalate
Potassium Oxalate/Sodium Fluoride
Sodium Citrate
Sodium EDTA
Sodium Fluoride
Sodium Fluoride/Potassium Oxalate
Sodium Heparin

 

HemaCare has the capability to prepare and provide plasma products according to your specifications:

 

• Specialized research donor subject recruitment
• Customized collections

Learn more

 

HemaCare can source disease state material from donors with autoimmune disorders, infectious diseases, or certain rare disorders (among others).  Some examples of disease states include:

 

• Celiac Disease
• Crohn’s disease
• Lupus (SLE)
• Psoriasis
• Rheumatoid Arthritis
• Rheumatoid Factor (RF)
• HIV, HPV, HBV & HCV positive donors

If you don’t see a product you are looking for, contact us! (877) 397-3087.

 

Packaging and shipping specifications play an important role in maintaining the quality of your product.  We package and ship all products to your specifications.

 

Temperature monitoring data tracking devices are available for use at your request.

 

Our healthy donor subjects for research products are screened with the same stringent regulations and requirements as donors who donate transfusable blood components.

 

Donors must:

• Be at least 18 years old.
• Weigh at least 140 lbs.
• Be in good health and feeling well.
• Not be pregnant.
• Meet protocol specifications, i.e. CBC lab tests.
• Be prescreened for evidence of transmissible infectious diseases (HIV, Hepatitis B, and Hepatitis C) before donation.  This panel of tests is repeated with each product collection.
• Have adequate peripheral veins for apheresis.
• Complete and sign a Donor History Questionnaire developed by the AABB and accepted by the FDA and a procedure-specific consent form prior to the collection procedure.  All consents and protocols have been approved by an independent biomedical review board (IRB).